Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19...
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs
About this item
Full title
Author / Creator
Brouwer, Jurriaan M J L , Nijenhuis, Marga , Soree, Bianca , Guchelaar, Henk-Jan , Swen, Jesse J , van Schaik, Ron H N , Weide, Jan van der , Rongen, Gerard A P J M , Buunk, Anne-Marie , de Boer-Veger, Nienke J , Houwink, Elisa J F , van Westrhenen, Roos , Wilffert, Bob , Deneer, Vera H M and Mulder, Hans
Publisher
England: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
The Dutch Pharmacogenetics Working Group (DPWG) guideline presented here, presents the gene-drug interaction between the genes CYP2C19 and CYP2D6 and antidepressants of the selective serotonin reuptake inhibitor type (SSRIs). Both genes' genotypes are translated into predicted normal metabolizer (NM), intermediate metabolizer (IM), poor metabolizer...
Alternative Titles
Full title
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9553948
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9553948
Other Identifiers
ISSN
1018-4813
E-ISSN
1476-5438
DOI
10.1038/s41431-021-01004-7
